U.S. markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
78.67-1.16 (-1.45%)
At close: 4:02PM EDT

78.90 +0.23 (0.29%)
After hours: 7:08PM EDT

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908 740 4000
http://www.merck.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full Time Employees71,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Kenneth C. FrazierChairman, Pres & CEO6.64M28.28M1955
Mr. Robert M. DavisExec. VP of Global Services & CFO3.29M10.18M1967
Ms. Jennifer L. ZacharyExec. VP, Gen. Counsel & Corp. Sec.2.47MN/A1978
Mr. Sanat ChattopadhyayExec. VP & Pres of Merck Manufacturing Division2.01M2.98M1960
Dr. Roger M. PerlmutterExec. VP & Pres of Merck Research Laboratories3.55MN/A1952
Mr. David Michael WilliamsChief Information & Digital OfficerN/AN/AN/A
Mr. Peter Dannenbaum CFAVP of Investor RelationsN/AN/AN/A
Michael W. FlemingSr. VP and Chief Ethics & Compliance OfficerN/AN/A1959
Jennifer MauerVP of Global CommunicationsN/AN/AN/A
Mr. Michael T. NallyChief Marketing Officer & Exec. VPN/AN/A1976
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents for cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs for infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Almac Discovery Ltd.; Skyhawk Therapeutics, Inc.; Ridgeback Biotherapeutics; Shanghai Junshi Biosciences Co., Ltd.; FUJIFILM Corporation; and Intec Pharma Ltd. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers; and physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Corporate Governance

Merck & Co., Inc.’s ISS Governance QualityScore as of October 6, 2020 is 2. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 2; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.